6505-01-653-1569 Dantrolene sodium for injection
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 0
- Last price paid
- …
- Standard price
- $3,350.25 per VI
- DLA's catalog price, not a price paid
- Approved sources
- 3
- Awards on record
- 9
- 2017 to 2025
- DLA demand
- –
Identification
- Item name
- Dantrolene sodium for injection
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 14-MAR-16
- Unit
- VI
- NSN
- 6505-01-653-1569
- NIIN
- 01-653-1569
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # | Listed in |
|---|---|---|---|---|---|
| CARDINAL HEALTH, INC. | 00E55 | A (Active) | 5 (Secondary reference) / 2 (An item-identifying number) | NDC42367-0540-32 | DLA approved-source file |
| AMERISOURCEBERGEN DRUG CORP | 1XUY5 | A (Active) | 5 (Secondary reference) / 2 (An item-identifying number) | NDC42367-0540-32 | DLA approved-source file |
| EAGLE PHARMACEUTICALS, INC.Won before | 7LL94 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC42367-0540-32 | DLA approved-source file |
| 64616 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | 6505NCM162633 | FLIS part list | |
| 89875 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | 1398188 | FLIS part list |
Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3004909240 (Medicaments affect central nervous system, nesoi)
- PINC
- 0037569
- Criticality (CRIT CD)
- X
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 5From a sole source contractor that is not the manufacturer | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 5From a sole source contractor that is not the manufacturer | ZCommercial or off-the-shelf item | ||||
| MC55 | Marine Corps (DM) | 5From a sole source contractor that is not the manufacturer | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 5From a sole source contractor that is not the manufacturer | ZCommercial or off-the-shelf item | ||||
| ZE01 | New zealand (ZE) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | VI | $2,561.65 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | VI | $2,561.65 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Marine Corps (DM) | 14-JUL-2026 | VI | $2,561.65 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | VI | $2,561.65 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | VI | $3,350.25 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 0 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0073DIBBS only | 6505-01-653-1569 | Dantrolene sodium for injection | 9 | VI | $3,350.25 per VI | … | … | No set-aside | No | October 13, 2026 | October 16, 2026Closed |
→ These RFQs in the DIBBS list
Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 78 days, production 113 days (191 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
9 award lines since 2017, 2 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 7LL94EAGLE PHARMACEUTICALS, INC. | 8 | September 17, 2025 |
| 0ZSM5NAR MEDICAL DEPOT, LLC | 1 | February 24, 2017 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2025 | 5 | 1 |
| 2018 | 3 | 1 |
| 2017 | 1 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
9 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | EAGLE PHARMACEUTICALS, INC. | $112,793 | 8 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2DP25P0664From the item's award history | September 17, 2025 | EAGLE PHARMACEUTICALS, INC. | $5,293 |
| SPE2DP25P0666From the item's award history | September 4, 2025 | EAGLE PHARMACEUTICALS, INC. | $10,585 |
| SPE2DP25P0670From the item's award history | September 4, 2025 | EAGLE PHARMACEUTICALS, INC. | $10,585 |
| SPE2DP25P0663From the item's award history | September 3, 2025 | EAGLE PHARMACEUTICALS, INC. | $10,585 |
| SPE2DP25P0317From the item's award history | April 30, 2025 | EAGLE PHARMACEUTICALS, INC. | $42,341 |
| SPE2DP19P0121From the item's award history | October 30, 2018 | EAGLE PHARMACEUTICALS, INC. | $3,854 |
| SPE2DP18P0464From the item's award history | May 23, 2018 | EAGLE PHARMACEUTICALS, INC. | $24,410 |
| SPE2DP18F1300From the item's award history | January 24, 2018 | EAGLE PHARMACEUTICALS, INC. | $5,139 |
| SPE2DP17P0382From the item's award history | February 24, 2017 | NAR MEDICAL DEPOT, LLC | $0 |
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.